Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer.
- Resource Type
- Article
- Authors
- Mehta, Sandhya; Xie, Jipan; Ionescu-Ittu, Raluca; Nie, Xiaoyu; Kwong, Winghan J.
- Source
- Oncology & Therapy; Dec2023, Vol. 11 Issue 4, p481-493, 13p
- Subject
- THERAPEUTIC use of monoclonal antibodies
THERAPEUTIC use of antineoplastic agents
HORMONE therapy
TRASTUZUMAB
TREATMENT duration
METASTASIS
RETROSPECTIVE studies
ACQUISITION of data
TREATMENT effectiveness
CANCER patients
RESEARCH funding
KAPLAN-Meier estimator
MEDICAL records
DESCRIPTIVE statistics
DEMOGRAPHY
TUMOR markers
BREAST tumors
LONGITUDINAL method
- Language
- ISSN
- 23661070
Copyright of Oncology & Therapy is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)